Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Carriers of the
APOE
E4 allele have an increased risk of developing Alzheimer's disease. However, it is less clear whether
APOE
E4 status may also be involved in non-pathological cognitive ageing. The present study investigated the associations between
APOE
genotypes and cognitive change over 8 years in older community-dwelling individuals.
APOE
genotype was determined in 501 participants of the Lothian Birth Cohort 1921, whose intelligence had been measured in childhood in the Scottish Mental Survey 1932. A polymorphic variant of
TOMM40
(rs10524523) was included to differentiate between the effects of the
APOE
E3 and E4 allelic variants. Cognitive performance on the domains of verbal memory, abstract reasoning and verbal fluency was assessed at mean age 79 years (
n
=501), and again at mean ages of 83 (
n
=284) and 87 (
n
=187). Using linear mixed models adjusted for demographic variables, vascular risk factors and IQ at age 11 years, possession of the
APOE
E4 allele was associated with a higher relative rate of cognitive decline over the subsequent 8 years for verbal memory and abstract reasoning. Individuals with the long allelic variant of
TOMM40
, which is linked to
APOE
E4, showed similar results. Verbal fluency was not affected by
APOE
E4 status.
APOE
E2 status was not associated with change in cognitive performance over 8 years. In non-demented older individuals, possession of the
APOE
E4 allele predicted a higher rate of cognitive decline on tests of verbal memory and abstract reasoning between 79 and 87 years. Thus, possession of the
APOE
E4 allele may not only predispose to Alzheimer's disease, but also appears to be a risk factor for non-pathological decline in verbal memory and abstract reasoning in the ninth decade of life.